(1)
Pinto, M. E.; Manrique, H. A. Withdrawal of Sibutramine for Cardiovascular Disease Risk. Rev Peru Med Exp Salud Publica 2010, 27 (3). https://doi.org/10.17843/rpmesp.2010.273.1517.